It has been a tremendous feat of public health, but one America is in danger of losing. Ninety percent of infants who get hepatitis B will develop a long-term infection which can lead to liver failure, constant hospitalizations, and ultimately death.
But since the CDC started recommending the hepatitis B vaccine at birth over three decades ago, the number of infections in children has dropped by over 99%.
The reasons to vaccinate
After Robert F. Kennedy Jr. became Secretary of Health and Human Services, he dropped the world-renowned doctors, scientists, and public health officials who made up the CDC’s Advisory Committee on Immunization Practices (ACIP). He filled the committee with people who have less expertise and are more partisan.
On December 16th, the CDC accepted the new ACIP’s recommendation against what has been so successful since 1991. They recommended using individual-based decision-making in choosing whether to give the hepatitis B vaccine at birth when mothers test negative in pregnancy. Parents must now opt in to their children getting the vaccine.
Pediatricians such as myself largely view this as a mistake. Of course, parents are not overjoyed when their newborn gets stuck with a needle, but the benefits are clear, and no quality studies have found that this protection comes with long-term negative health consequences.
First, the CDC’s guidance from 1991–2025 has worked tremendously in lowering rates of acute hepatitis B in children — again, by 99%. Infection rates will likely climb if families now need to opt into getting the hepatitis B vaccine.
Second, mothers commonly get tested for hepatitis B early in pregnancy. It is possible to get infected after this testing or for the testing to be falsely reassuring. While both of these are infrequent, I have taken care of many families in Allegheny County who have been affected by changes in testing over the course of a pregnancy.
Third, the hepatitis B vaccine is very safe, and there is no evidence that giving it after birth is harmful. True allergic reactions occur in less than 1 in 1.3 million, and pediatricians are quite good at managing this. No reliable, large-scale studies have found a connection between hepatitis B vaccination and long-term consequences, such as sudden infant death syndrome, seizures or autoimmune conditions.
A questionable decision
I wholeheartedly believe that medicine needs to continuously be critical of itself and its recommendations. Most importantly though medicine needs to act on quality data answering thoughtful questions. This does not appear to be the case with this decision.
The press release about this recommendation included the presentations ACIP reviewed prior to its vote. One displayed a graph showing the massive reduction in hepatitis B rates from 1990 to now, and then stated that this was not due to the vaccine but better hepatitis B screening, dialysis practices, blood transfusion protocols, safe sex practices, and needle exchange programs.
While those improvements certainly had some effect, there would need to be some impressive evidence to show that the hepatitis B vaccine did not play a major role in this. The only evidence offered was that chronic hepatitis B cases are increasing in adults, while ignoring the significant data that they are better in the age groups who grew up under universal vaccination.
Another presentation brought up the interesting point that European countries largely do not recommend hepatitis B vaccine at birth. The key differences between the U.S. and Europe were not mentioned though.
In the United Kingdom, for example, even without the official recommendation, the rate of hepatitis B screening in pregnancy is 99.8% compared to 84 to 88% in the U.S. Having some form of socialized medicine, these countries also are on the hook to pay for whatever recommendations they make, so they are more conservative in requiring some kinds of medical care.
We need good data, not politics
The U.S. has made tremendous progress in combating disease over the past few decades, not least in the spread of vaccination. I worry that this will be just the beginning of major public health missteps, as those making decisions base their decisions on politics and not legitimate science.
We must demand good data and thoughtful discourse to keep all Americans, but especially our children, healthy.
Hasanga Samaraweera is a pediatrician practicing in Pittsburgh.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.